Loading clinical trials...
Loading clinical trials...
GORE VIABAHN Endoprosthesis Versus Bare Nitinol Stent in the Treatment of Long Lesion (>8cm) Superficial Femoral Artery Occlusive Disease
Conditions
Interventions
GORE VIABAHN Endoprosthesis
Bare Nitinol Stent
Locations
15
United States
Mayo Clinic Phoenix
Phoenix, Arizona, United States
Arkansas Heart
Little Rock, Arkansas, United States
Holy Cross Hospital
Fort Lauderdale, Florida, United States
Vascular Surgical Associate
Austell, Georgia, United States
Midwest Heart Foundation
Lombard, Illinois, United States
Midwest Institute for Minimally Invasive Therapy
Melrose Park, Illinois, United States
Start Date
September 1, 2005
Primary Completion Date
January 1, 2011
Completion Date
January 1, 2011
Last Updated
June 4, 2012
NCT06656988
NCT04927156
NCT06399809
NCT03404180
NCT05009602
NCT05662787
Lead Sponsor
W.L.Gore & Associates
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions